Biothermal: Complexities of Commercial Cold Chain

Global commercial distribution of temperature-sensitive pharmaceuticals can seem daunting for both established and emerging life sciences organizations. Cold chain packaging and shipping considerations change as a company moves from clinical to commercial operations, and new challenges related to COVID-19 still impact shipping. But that’s not all. The shift from chemically synthesized to more biologic drugs also requires greater temperature control.